drugset / Trial / NCT03151720
A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to establish the relative bioavailability of Xisimin (loratadine) compared to Clarityne in healthy participants receiving a single dose of 10 milligram (mg) under fasting condition as part of Cohort 1 and under fed condition as part of Cohort 2.
Timeline
- Start
- 2017-06-01
- Primary completion
- 2017-07-08
- Completion
- 2017-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loratadine | Small molecule | 10 mg | Oral |
Indications
No indication recorded.